Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Racotumomab> ?p ?o. }
Showing items 1 to 53 of
53
with 100 items per page.
- Racotumomab abstract "Racotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors that is currently under clinical development by Recombio, an international public-private consortium with the participation of the Center of Molecular Immunology at Havana, Cuba (CIM) and researchers from Buenos Aires University and National University of Quilmes in Argentina. It induces the patient's immune system to generate a response against a cancer-specific molecular target with the purpose of blocking tumor growth, slowing disease progression and ultimately increasing patient survival.Racotumomab triggers an immune response against the tumor antigen N-glycolil (NGc) GM3 (NGcGM3), a type of ganglioside present on the cell surface of malignant cells from lung and breast, melanoma, as well as neuroectodermal pediatric tumors. Racotumomab has successfully completed a proof-of concept clinical trial in advanced non-small cell lung cancer (NSCLC) and is currently being tested in a large, multinational study for the same indication.".
- Racotumomab atcPrefix "none".
- Racotumomab casNumber "946832-34-4".
- Racotumomab fdaUniiCode "52G405U1E5".
- Racotumomab wikiPageID "33058007".
- Racotumomab wikiPageRevisionID "570935927".
- Racotumomab atcPrefix "none".
- Racotumomab c "6476".
- Racotumomab casNumber "946832".
- Racotumomab chemspiderid "NA".
- Racotumomab h "9922".
- Racotumomab hasPhotoCollection Racotumomab.
- Racotumomab mabType "mab".
- Racotumomab n "1712".
- Racotumomab o "2048".
- Racotumomab s "50".
- Racotumomab source "o".
- Racotumomab target "NGNA ganglioside".
- Racotumomab type "mab".
- Racotumomab unii "52".
- Racotumomab verifiedfields "changed".
- Racotumomab verifiedrevid "464379504".
- Racotumomab subject Category:Monoclonal_antibodies.
- Racotumomab type Abstraction100002137.
- Racotumomab type Antibody115027189.
- Racotumomab type Chemical114806838.
- Racotumomab type Compound114818238.
- Racotumomab type Macromolecule114944888.
- Racotumomab type Material114580897.
- Racotumomab type Matter100020827.
- Racotumomab type Molecule114682133.
- Racotumomab type MonoclonalAntibodies.
- Racotumomab type MonoclonalAntibody115029781.
- Racotumomab type OrganicCompound114727670.
- Racotumomab type Part113809207.
- Racotumomab type PhysicalEntity100001930.
- Racotumomab type Protein114728724.
- Racotumomab type Relation100031921.
- Racotumomab type Substance100019613.
- Racotumomab type Thing100002452.
- Racotumomab type Unit109465459.
- Racotumomab type Drug.
- Racotumomab type FunctionalSubstance.
- Racotumomab comment "Racotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors that is currently under clinical development by Recombio, an international public-private consortium with the participation of the Center of Molecular Immunology at Havana, Cuba (CIM) and researchers from Buenos Aires University and National University of Quilmes in Argentina.".
- Racotumomab label "Racotumomab".
- Racotumomab label "Racotumomab".
- Racotumomab sameAs Racotumomab.
- Racotumomab sameAs m.0h55rx4.
- Racotumomab sameAs Q7279820.
- Racotumomab sameAs Q7279820.
- Racotumomab sameAs Racotumomab.
- Racotumomab wasDerivedFrom Racotumomab?oldid=570935927.
- Racotumomab isPrimaryTopicOf Racotumomab.